Washington Report

Oct 01, 2008
Pharmaceutical Executive
Congressional leaders ready campaign to curb Medicare drug plans.
Sep 01, 2008
Pharmaceutical Executive
FDA missteps and global outsourcing are drawing Congressional scrutiny and prompting new oversight approaches
Aug 01, 2008
Pharmaceutical Executive
FDA's new sentinel system shows the pendulum swing toward safety won't swing back anytime soon
Jul 01, 2008
Pharmaceutical Executive
Rare disease treatments are riding high as patient adcovates, pharma companies, and government officials celebrate the ODA's 25th anniversary
Jun 01, 2008
Pharmaceutical Executive
US presidential hopefuls look to comparative effectiveness analysis to address price and access issues
May 01, 2008
Pharmaceutical Executive
FDA is being pressured to get its act together. The agency says it needs more money and more people to get approvals out the door
Apr 01, 2008
Pharmaceutical Executive
International outsourcing carries risks for marketers and regulatory challenges for FDA
Mar 01, 2008
Pharmaceutical Executive
Congress is firing plenty of ammunition at pharma companies—and the regulators
Feb 01, 2008
Pharmaceutical Executive
Congress blocked DTC user fees, Reagan-Udall, field force reforms while slightly bumping FDA's budget
Jan 01, 2008
Pharmaceutical Executive
Pricing, safety, comparative effectiveness, patents, and biosimilars top 2008's policy agenda
native1_300x100
lorem ipsum